Cargando…
Evidence for tankyrases as antineoplastic targets in lung cancer
BACKGROUND: New pharmacologic targets are urgently needed to treat or prevent lung cancer, the most common cause of cancer death for men and women. This study identified one such target. This is the canonical Wnt signaling pathway, which is deregulated in cancers, including those lacking adenomatous...
Autores principales: | Busch, Alexander M, Johnson, Kevin C, Stan, Radu V, Sanglikar, Aarti, Ahmed, Yashi, Dmitrovsky, Ethan, Freemantle, Sarah J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644501/ https://www.ncbi.nlm.nih.gov/pubmed/23621985 http://dx.doi.org/10.1186/1471-2407-13-211 |
Ejemplares similares
-
Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation
por: Bhardwaj, Amit, et al.
Publicado: (2017) -
Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting
por: Snow, Grace E, et al.
Publicado: (2009) -
Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas
por: Chinyengetere, Fadzai, et al.
Publicado: (2015) -
Tankyrase 1 and Tankyrase 2 Are Essential but Redundant for Mouse Embryonic Development
por: Chiang, Y. Jeffrey, et al.
Publicado: (2008) -
The telomeric PARP, tankyrases, as targets for cancer therapy
por: Seimiya, H
Publicado: (2006)